WEST PALM BEACH, FL–(Marketwired – Jan 11, 2016) – Medical Mime, an electronic health records company owned by Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAW), announced today that its M2PRO product earned “Meaningful Use” Stage 2 certification as a “Complete Ambulatory EHR” from the Office of the National Coordinator for Health Information Technology (ONC). The designation means Medical Mime’s program conforms to the standards and certification criteria adopted by the Secretary of Health and Human Services (HHS). The designation also means that Medical Mime’s EHR is included on the Certified Health IT Product List (CHPL), known as “Chapel.”
The certification provides assurance to providers that the EHR meets the technological capability, functionality, and security requirements adopted by HHS. Certification also gives providers — and patients — confidence that M2PRO is secure and meets standards for interoperability, which is the capability for one software system to work with other systems to share information. “Meaningful Use” refers to a number of criteria that gauge how a healthcare technology product improves health delivery in a meaningful way.
“We have always known that Medical Mime’s M2PRO is a robust product for physicians and other providers who practice in outpatient settings. However, designation from the ONC and inclusion on its product list is the ultimate endorsement,” said Seamus Lagan, CEO of Medical Mime’s parent company, Rennova Health. “In addition, this designation will likely translate into increased product demand and market share, not only among those provider categories where we have historically done well, but also among the wider physician universe.”
Unlike all other EHRs listed by CHPL, Medical Mime is wholly dictation-based and takes advantage of the most advanced speech recognition tools and natural language software to process physician’s notes. Entering details of a patient encounter using dictation, instead of clicks on a mouse pad or touch screen, has demonstrated itself to be a faster and easier method of recording health information.
“We’re gratified to learn that our product has made the cut to be included among this elite group,” said David Cooper, director of sales of Medical Mime. “It’s a testament to the efficacy of our dictation-based approach to managing health records and confirmation that ease-of-use for doctors is a top priority.”
Certification was conducted by Drummond Group, an independent testing and certification company recognized by the ONC.
About Rennova Health
Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAW) owns and operates five diagnostics laboratories across the United States that provide clinical testing services specializing in toxicology testing for pain management clinics, drug and alcohol rehabilitation facilities and neurotransmitter testing. It offers its customers a complete, turnkey software product including: a proprietary laboratory ordering and reporting application, an advanced laboratory information management system, electronic health records, and an industry-leading platform for interpreting and reporting complex test results to physicians. Rennova’s software is differentiated from that of its competitors by the breadth of its services, each of which is branded separately and is made available to physician groups in whole or in part. The software permits efficient and easy ordering and reporting, electronic health records integration, medical billing services and compliance, and diagnostic interpretation. For more information see www.rennovahealth.com.
About Medical Mime
Medical Mime, based in Brentwood, Tenn., is a dictation-based electronic health records (EHR) company and a wholly owned subsidiary of Rennova Health, Inc. (NASDAQ: RNVA). The Medical Mime EHR is currently used by surgical specialists as well as primary care and other office-based physicians. In addition, Medical Mime recently developed a new version of the EHR system specifically created to serve the needs of mental health providers working in substance abuse and drug and alcohol rehabilitation facilities.
Rennova Health Safe Harbor Statement
This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to significant risks and uncertainties, and actual results could differ materially from those projected and Rennova Health cautions investors not to place undue reliance on the forward-looking statements contained in this release. Important factors that could cause Rennova Health’s actual results or performance to differ materially from the forward-looking statements include those set forth in Rennova’s filings with the Securities and Exchange Commission, which filings are available on www.sec.gov. Rennova Health undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances, except as may be required by law.